Tag: new drug application

Glenmark Ryaltris nasal spray is used for the treatment of seasonal allergic rhinitis in adults

Glenmark’s Ryaltris nasal spray receives approval from US FDA

Aptar Pharma has announced that its VP3 multidose device is the delivery system for Glenmark’s Ryaltris nasal spray, which recently received New Drug Application...

GSK’s Zejula gets FDA approval to treat women with platinum-responsive advanced...

GlaxoSmithKline announced the US Food and Drug Administration (FDA) approved the company’s supplemental New Drug Application (sNDA) for Zejula (niraparib), an oral, once-daily poly...

This function has been disabled for HealthTekPak.

error: Content is protected !!